Science ❯ Biotechnology

Clinical Trials

Psychedelic Research Antibodies Nasal COVID-19 Vaccine Gene Mutation Medical Research Cancer Immunotherapy Safety Testing Trial Design Human Trials Cancer Research Metabolic Diseases Drug Development Stages Health Innovations Gene Therapy Research Phase 3 Studies Cancer Treatment Phase 3 Trials

Mirum to Acquire Bluejay Therapeutics in Up to $820 Million Deal for Hepatitis D Drug

The rare-disease specialist moves to add a Phase 3 hepatitis D antibody ahead of a 2026 efficacy readout.

Sarepta Shares Plunge After ESSENCE Phase 3 Miss in Duchenne Trial

FDA Setback Puts uniQure’s Huntington’s Gene Therapy Filing in Doubt

First Human Trial Finds Enteral Ventilation Procedure Tolerable in Healthy Volunteers

Samsung Invests $110 Million in Grail to Bring Galleri Cancer Test to Asia

AbbVie Agrees to Buy Gilgamesh’s Bretisilocin for Up to $1.2 Billion

FDA Rejects Replimune’s RP1 Melanoma Immunotherapy